Cargando…
EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment
EZH2 inhibitors (EZH2i), a class of small-molecule inhibitors that target EZH2 to exert anti-tumor functions, have just been approved by the US Food and Drug Administration (FDA) in treatment of adults and adolescents with locally advanced or metastatic epithelioid sarcoma. The application of EZH2i...
Autores principales: | Li, Chen, Song, Jiagui, Guo, Zhengyang, Gong, Yueqing, Zhang, Tengrui, Huang, Jiaqi, Cheng, Rui, Yu, Xiaotong, Li, Yanfang, Chen, Li, Ma, Xiaojuan, Sun, Yan, Wang, Yan, Xue, Lixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010515/ https://www.ncbi.nlm.nih.gov/pubmed/35432300 http://dx.doi.org/10.3389/fimmu.2022.857808 |
Ejemplares similares
-
Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor
por: Zhang, Tengrui, et al.
Publicado: (2022) -
Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors
por: Li, Chen, et al.
Publicado: (2021) -
Symphony of epigenetic and metabolic regulation—interaction between the histone methyltransferase EZH2 and metabolism of tumor
por: Zhang, Tengrui, et al.
Publicado: (2020) -
Easy or Not—The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity
por: Huang, Jiaqi, et al.
Publicado: (2021) -
Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer
por: Wang, Ya-fang, et al.
Publicado: (2022)